1591 related articles for article (PubMed ID: 26582929)
21. The Sequential Development of Antiglomerular Basement Membrane Nephritis and Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Ohashi N; Namikawa A; Ono M; Iwakura T; Isobe S; Tsuji T; Kato A; Yasuda H
Intern Med; 2017 Oct; 56(19):2617-2621. PubMed ID: 28883245
[TBL] [Abstract][Full Text] [Related]
22. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.
Franssen CF; Huitema MG; Muller Kobold AC; Oost-Kort WW; Limburg PC; Tiebosch A; Stegeman CA; Kallenberg CG; Tervaert JW
J Am Soc Nephrol; 1999 Jul; 10(7):1506-15. PubMed ID: 10405206
[TBL] [Abstract][Full Text] [Related]
23. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
[TBL] [Abstract][Full Text] [Related]
24. A novel mouse model for MPO-ANCA-associated glomerulonephritis.
Yumura W; Itabashi M; Ishida-Okawara A; Tomizawa K; Yamashita J; Kaneshiro Y; Nihei H; Suzuki K
Microbiol Immunol; 2006; 50(2):149-57. PubMed ID: 16490933
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
26. Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.
Xu PC; Gou SJ; Yang XW; Cui Z; Jia XY; Chen M; Zhao MH
BMC Immunol; 2012 Mar; 13():10. PubMed ID: 22404873
[TBL] [Abstract][Full Text] [Related]
27. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
[TBL] [Abstract][Full Text] [Related]
28. The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
Arimura Y; Kawashima S; Yoshihara K; Komagata Y; Kaname S; Yamada A
Clin Exp Nephrol; 2013 Oct; 17(5):634-637. PubMed ID: 23504409
[TBL] [Abstract][Full Text] [Related]
29. A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis.
Suzuki K; Nagao T; Itabashi M; Hamano Y; Sugamata R; Yamazaki Y; Yumura W; Tsukita S; Wang PC; Nakayama T; Suzuki K
Nephrol Dial Transplant; 2014 Jun; 29(6):1168-77. PubMed ID: 24319012
[TBL] [Abstract][Full Text] [Related]
30. Is there a role for TNFα blockade in ANCA-associated vasculitis and glomerulonephritis?
McAdoo SP; Pusey CD
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i80-i88. PubMed ID: 28391344
[TBL] [Abstract][Full Text] [Related]
31. Endothelial NF-
Choi M; Schreiber A; Eulenberg-Gustavus C; Scheidereit C; Kamps J; Kettritz R
J Am Soc Nephrol; 2017 Nov; 28(11):3191-3204. PubMed ID: 28687535
[TBL] [Abstract][Full Text] [Related]
32. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.
Heeringa P; Brouwer E; Klok PA; Huitema MG; van den Born J; Weening JJ; Kallenberg CG
Am J Pathol; 1996 Nov; 149(5):1695-706. PubMed ID: 8909258
[TBL] [Abstract][Full Text] [Related]
34. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells.
Kain R; Matsui K; Exner M; Binder S; Schaffner G; Sommer EM; Kerjaschki D
J Exp Med; 1995 Feb; 181(2):585-97. PubMed ID: 7836914
[TBL] [Abstract][Full Text] [Related]
35. The role of neutrophils in causing antineutrophil cytoplasmic autoantibody-associated vasculitis.
Schreiber A; Choi M
Curr Opin Hematol; 2015 Jan; 22(1):60-6. PubMed ID: 25394311
[TBL] [Abstract][Full Text] [Related]
36. Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies.
Toledo Perdomo K; Ortega Salas R; Pérez-Sáez MJ; Esquivias de Motta E; Espinosa Hernández M; López Andreu M; López Rubio F; Aljama García P
Nefrologia; 2011; 31(1):113-5. PubMed ID: 21270926
[No Abstract] [Full Text] [Related]
37. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
[TBL] [Abstract][Full Text] [Related]
38. CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis.
Rousselle A; Sonnemann J; Amann K; Mildner A; Lodka D; Kling L; Bieringer M; Schneider U; Leutz A; Enghard P; Kettritz R; Schreiber A
Ann Rheum Dis; 2022 Aug; 81(8):1162-1172. PubMed ID: 35418479
[TBL] [Abstract][Full Text] [Related]
39. Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine.
Nagao T; Kusunoki R; Iwamura C; Kobayashi S; Yumura W; Kameoka Y; Nakayama T; Suzuki K
Microbiol Immunol; 2013 Sep; 57(9):640-50. PubMed ID: 23829825
[TBL] [Abstract][Full Text] [Related]
40. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
